Adverse events tied to proliferative diabetic retinopathy affected 6.7% and 6.1% of remigromig patients, versus 0.9% with ranibizumab; BAROLO continues.
Mazda currently has a strong vibe of being a "company that is quietly regaining its underlying strength". It is not flashy, ...
A large real-world data study has established sex- and age-stratified reference intervals for serum CA125 using five ...
Researchers have developed ProD, a visualizable filter feature selection method that ranks variables by measuring the ...
Can affection exist as a one-way street? From the theory of friendship in Aristotle's Nicomachean EthicsFor example, suppose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results